Latest news
Loading news…
ProJenX
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New Suffolk, New York, United States Founded 2021 1-10 employees For Profit
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- IT spend
- $239K
Company Info
- Founded
- 2021
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 27
- HQ
- New Suffolk, New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 3.7
- Trend (30d)
- 3.9
- Trend (90d)
- 3.5
- Last leadership hire
- May 18, 2022
Key People at ProJenX
President & Chief Executive Officer
Co-Founder & VP Operations
2
professional contacts at ProJenX
Contact execs at ProJenX →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ProJenX
Loading news…
FAQs about ProJenX
People who checked this page also checked these
Browse the full Acquirezy directory.